Elagolix Completed Phase 1 Trials for Folliculogenesis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01403038An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females